Cryo and Compression Therapy After TKA and UKA

NCT05572359 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 208

Last updated 2026-02-27

No results posted yet for this study

Summary

The goal of this clinical trial is to test the use of a cold and compression brace during the first 6 weeks after surgery in patients who had a total or partial knee replacement.

The main question\[s\] it aims to answer are:

* What is the effect of the use of cryo- and compression therapy during the first 6 postoperative weeks after knee replacement surgery on pain in rest?
* What is the effect of the use of cryo- and compression therapy during the first 6 postoperative weeks after knee replacement surgery on pain while loading, opioid use, functioning, patient satisfaction and general health, and do participants comply with the therapy?

Participants will be asked to use the cold and compression brace during the six weeks after surgery five times a day, for a maximum of 20 minutes. Researchers will compare with usual care to see the effect on pain, opioid use, functioning, satisfaction and general health.

Conditions

  • Osteo Arthritis Knee

Interventions

DEVICE

cryo-and compression brace

patients in the intervention groups are instructed to use the cryo- and compression brace during the six postoperative weeks five times a day, for a maximum of 20 minutes. The amount of compression is dependent on a patients' own preference.

Sponsors & Collaborators

  • U-sport

    collaborator UNKNOWN
  • Dutch Arthroplasty Register (LROI)

    collaborator UNKNOWN
  • Martini Hospital Groningen

    lead OTHER

Principal Investigators

  • Reinoud W. Brouwer, MD PhD · Martini Hospital: Martini Ziekenhuis

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-25
Primary Completion
2026-02-16
Completion
2026-02-16

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05572359 on ClinicalTrials.gov